chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Speech disorder, Wheezing
Clinical narrative: Chest tightness; Wheezing; Cold sweat; Flushed; High BP; Difficulty speaking; This is a spontaneous report from a contactable consumer. A 57-year-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EN6208), via an unspecified route of administration in left arm on 21Mar2021 at 18:00 (age at the time of vaccination was 57-year-old) as a single dose for COVID-19 immunization. The patient did not receive any other vaccine in four weeks of COVID-19 vaccination. The patient did not experience COVID prior vaccination. The patient did not test for COVID-19 post vaccination. The patient's medical history included asthma, allergies, prior anaphylaxis to allergy shots, beta-thalassemia trait, sulfites allergy, pollens and molds allergy. The patient's concomitant medications included fluticasone propionate, salmeterol xinafoate (ADVAIR) taken for an unspecified indication, start and stop date were not reported; bupropion (BUPROPION) taken for an unspecified indication, start and stop date were not reported; azelastine; fluticasone (AZELASTINE; FLUTICASONE) taken for an unspecified indication, start and stop date were not reported. On 21Mar2021 at 18:15, the patient experienced wheezing, cold sweat, flushed, high BP, difficulty speaking, chest tightness. The events resulted in doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. The patient received epinephrine, albuterol, benadryl, solumedrol IV as treatment medication for the events. The outcome of the events was resolving.  Follow-up attempts are possible. Further information is expected.
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Axillary pain, Chest pain, Pain in extremity, Rash, Sensitive skin
Clinical narrative: Left under arm pain; chest (pectoral) pain; Lymphadenothopy.; Developed rash on left side of spine between shoulder blades.; This is a spontaneous report received from a contactable consumer, the patient. A 46-years-old male patient received his second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL9264) via an unspecified route of administration in right arm on 10Mar2021 at 16:00 (at the age of 46 years old) hours as single dose, for COVID-19 immunisation. No known Medical history. The patient did not have any allergies to food, medications, or other products. The patient previously took of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL9262) via an unspecified route of administration in left arm on 10Feb2021 at 16:00 hours as single dose, for COVID-19 immunisation and the events were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. No Concomitant medication. The patient did not receive any other medications or vaccines within 4 weeks prior to the vaccination. On 11Mar2021 at 5:00 hours, the patient experienced Left under arm pain and chest (pectoral) pain, Lymphadenothopy. Developed rash on left side of spine between shoulder blades. It was a painful bumpy rash about the size of a silver dollar. The lymph node issues began within hours of second shot and had not improved in 2 weeks. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. The patient did not receive any treatment for events. The clinical outcome of events painful left arm, chest pain, lymphadenopathy and rash were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chest pain, Lymphadenopathy, Pain in extremity, Rash
Clinical narrative: Left under arm pain; chest (pectoral) pain; Lymphadenothopy.; Developed rash on left side of spine between shoulder blades.; This is a spontaneous report received from a contactable consumer, the patient. A 46-years-old male patient received his second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL9264) via an unspecified route of administration in right arm on 10Mar2021 at 16:00 (at the age of 46 years old) hours as single dose, for COVID-19 immunisation. No known Medical history. The patient did not have any allergies to food, medications, or other products. The patient previously took of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL9262) via an unspecified route of administration in left arm on 10Feb2021 at 16:00 hours as single dose, for COVID-19 immunisation and the events were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. No Concomitant medication. The patient did not receive any other medications or vaccines within 4 weeks prior to the vaccination. On 11Mar2021 at 5:00 hours, the patient experienced Left under arm pain and chest (pectoral) pain, Lymphadenothopy. Developed rash on left side of spine between shoulder blades. It was a painful bumpy rash about the size of a silver dollar. The lymph node issues began within hours of second shot and had not improved in 2 weeks. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. The patient did not receive any treatment for events. The clinical outcome of events painful left arm, chest pain, lymphadenopathy and rash were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Injection site pain
Clinical narrative: Upper and forearm pain; felt weird; Numb feeling; Little discomfort; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ERZ613) via an unspecified route of administration in right arm on 22Mar2021 at 16:15 (at the age of 58-years-old) as first single dose for COVID-19 immunisation. The patient had no relevant past medical history. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient did not have any allergies to medications, food, or other products. Concomitant medication included melatonin 5mg (MANUFACTURER UNKNOWN) taken in some nights for an unknown indication. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. On 22Mar2021 at 16:15, the patient got the vaccine shot which felt weird when it happened, got deep numb feeling but no feeling of being pricked by needle. It seemed to take a little longer than expected. She had seen her dad get his and counted to 3 each time and she kept counting with hers, not sure when it got over. The patient felt that the injection was too high on her shoulder and told the clinician about it. It felt weird. The clinician said that the patient should have felt the stinging but she never felt that. After 15 minutes, the patient asked a different worker if the injection was too high and she said 2 or 3 fingers was appropriate and that it seemed okay. Injection looked to be at about where the third finger would be from her shoulder bone. It was higher than she has had shots before. The patient felt a little discomfort. At 18:15, two hours later, the patient experienced pain in her upper and forearm and had continued. Holding arm, it did not hurt but felt sore. There was sharp pain while movement especially in the upper arm. The adverse event did not result in doctor or other healthcare professional office or clinic visit or emergency room visit. Therapeutic measures taken included putting a heating pad on upper arm for about an hour for the reported events. The clinical outcome of the events felt weird, deep numb feeling, little discomfort and upper and forearm pain were not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Discomfort, Feeling abnormal, Hypoaesthesia, Pain in extremity
Clinical narrative: Upper and forearm pain; felt weird; Numb feeling; Little discomfort; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ERZ613) via an unspecified route of administration in right arm on 22Mar2021 at 16:15 (at the age of 58-years-old) as first single dose for COVID-19 immunisation. The patient had no relevant past medical history. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient did not have any allergies to medications, food, or other products. Concomitant medication included melatonin 5mg (MANUFACTURER UNKNOWN) taken in some nights for an unknown indication. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. On 22Mar2021 at 16:15, the patient got the vaccine shot which felt weird when it happened, got deep numb feeling but no feeling of being pricked by needle. It seemed to take a little longer than expected. She had seen her dad get his and counted to 3 each time and she kept counting with hers, not sure when it got over. The patient felt that the injection was too high on her shoulder and told the clinician about it. It felt weird. The clinician said that the patient should have felt the stinging but she never felt that. After 15 minutes, the patient asked a different worker if the injection was too high and she said 2 or 3 fingers was appropriate and that it seemed okay. Injection looked to be at about where the third finger would be from her shoulder bone. It was higher than she has had shots before. The patient felt a little discomfort. At 18:15, two hours later, the patient experienced pain in her upper and forearm and had continued. Holding arm, it did not hurt but felt sore. There was sharp pain while movement especially in the upper arm. The adverse event did not result in doctor or other healthcare professional office or clinic visit or emergency room visit. Therapeutic measures taken included putting a heating pad on upper arm for about an hour for the reported events. The clinical outcome of the events felt weird, deep numb feeling, little discomfort and upper and forearm pain were not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Hypoaesthesia, Mobility decreased
Clinical narrative: numbness in shoulder up into clavicle and neck/ numbness spread into the left side of my face; I became extremely tired about 2 hours after the shot; pain started in injection site/ could not lift my arm at all; This is a spontaneous report from a contactable other healthcare professional, the patient. A 43-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: 0155238-18053) via an unspecified route of administration on 11Mar2021 at 15:45 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included lyme since 1996 and chronic lyme but not have had a flare in 3 years. The patient had allergies to nickel, latex and almonds. The concomitant medications included biotin (MANUFACTURER UNKNOWN), omega 3 (MANUFACTURER UNKNOWN) and collagen (MANUFACTURER UNKNOWN). The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID19. On 11Mar2021 at 16:00, the patient experienced extreme numbness in shoulder up into clavicle and neck within 15 minutes and the numbness spreaded into the left side of the face as if she was giving Novacane. The patient became extremely tired about 2 hours after the shot and pain started in injection site and by the next morning, she could not lift her arm at all. The patient did not receive any treatment for reported events. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events numbness, tiredness and injection site pain were recovered on an unknown date of Mar2021.   No follow-up attempts are needed. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Hypoaesthesia, Vaccination site pain
Clinical narrative: numbness in shoulder up into clavicle and neck/ numbness spread into the left side of my face; I became extremely tired about 2 hours after the shot; pain started in injection site/ could not lift my arm at all; This is a spontaneous report from a contactable other healthcare professional, the patient. A 43-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: 0155238-18053) via an unspecified route of administration on 11Mar2021 at 15:45 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included lyme since 1996 and chronic lyme but not have had a flare in 3 years. The patient had allergies to nickel, latex and almonds. The concomitant medications included biotin (MANUFACTURER UNKNOWN), omega 3 (MANUFACTURER UNKNOWN) and collagen (MANUFACTURER UNKNOWN). The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID19. On 11Mar2021 at 16:00, the patient experienced extreme numbness in shoulder up into clavicle and neck within 15 minutes and the numbness spreaded into the left side of the face as if she was giving Novacane. The patient became extremely tired about 2 hours after the shot and pain started in injection site and by the next morning, she could not lift her arm at all. The patient did not receive any treatment for reported events. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events numbness, tiredness and injection site pain were recovered on an unknown date of Mar2021.   No follow-up attempts are needed. No further information is expected.
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Back pain, Mobility decreased, Pain, Pyrexia
Clinical narrative: Arthritis; pain down to the knee and lower back; pain down to the knee and lower back; hardly sleep.; This is a spontaneous report received from a contactable consumer, the patient. A 65-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6198) via an unspecified route of administration on 04Mar2021 at 09:15 hours (at the age of 65-years-old) as a single dose, for COVID-19 immunisation. Medical history included hypertension (controlled), cholesterol (controlled) and allergies to intravenous pyelogram (IVP) contrast dye (iodine based). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. Concomitant medication included ezetimibe (ZETIA) 10mg once and omeprazole (MANUFACTURER UNKNOWN) 20 mg once a day; both from an unknown date for an unknown indication. The patient did not receive any other vaccines within 4 weeks prior to the vaccination. On 08Mar2021 (after four days), the patient experienced a serious arthritis episode in the right hip with radiating pain down to the knee and lower back which as of this submission was still giving him problems. For a week, the patient could hardly sleep. The patient reported that even now (as of report), it hurts just lying on the bed. The patient had a doctor's appointment but cannot get in until 29 March (after the second shot). The patient did not receive any treatment for events. The clinical outcome of events arthritis, knee pain, lower back pain and sleep unwell were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Sleep disorder
Clinical narrative: Arthritis; pain down to the knee and lower back; pain down to the knee and lower back; hardly sleep.; This is a spontaneous report received from a contactable consumer, the patient. A 65-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6198) via an unspecified route of administration on 04Mar2021 at 09:15 hours (at the age of 65-years-old) as a single dose, for COVID-19 immunisation. Medical history included hypertension (controlled), cholesterol (controlled) and allergies to intravenous pyelogram (IVP) contrast dye (iodine based). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. Concomitant medication included ezetimibe (ZETIA) 10mg once and omeprazole (MANUFACTURER UNKNOWN) 20 mg once a day; both from an unknown date for an unknown indication. The patient did not receive any other vaccines within 4 weeks prior to the vaccination. On 08Mar2021 (after four days), the patient experienced a serious arthritis episode in the right hip with radiating pain down to the knee and lower back which as of this submission was still giving him problems. For a week, the patient could hardly sleep. The patient reported that even now (as of report), it hurts just lying on the bed. The patient had a doctor's appointment but cannot get in until 29 March (after the second shot). The patient did not receive any treatment for events. The clinical outcome of events arthritis, knee pain, lower back pain and sleep unwell were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Arthritis, Back pain, Poor quality sleep
Clinical narrative: Arthritis; pain down to the knee and lower back; pain down to the knee and lower back; hardly sleep.; This is a spontaneous report received from a contactable consumer, the patient. A 65-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6198) via an unspecified route of administration on 04Mar2021 at 09:15 hours (at the age of 65-years-old) as a single dose, for COVID-19 immunisation. Medical history included hypertension (controlled), cholesterol (controlled) and allergies to intravenous pyelogram (IVP) contrast dye (iodine based). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. Concomitant medication included ezetimibe (ZETIA) 10mg once and omeprazole (MANUFACTURER UNKNOWN) 20 mg once a day; both from an unknown date for an unknown indication. The patient did not receive any other vaccines within 4 weeks prior to the vaccination. On 08Mar2021 (after four days), the patient experienced a serious arthritis episode in the right hip with radiating pain down to the knee and lower back which as of this submission was still giving him problems. For a week, the patient could hardly sleep. The patient reported that even now (as of report), it hurts just lying on the bed. The patient had a doctor's appointment but cannot get in until 29 March (after the second shot). The patient did not receive any treatment for events. The clinical outcome of events arthritis, knee pain, lower back pain and sleep unwell were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pruritus, Rash, Rash erythematous
Clinical narrative: red rash on  waistline; little itchy  under skin; right lower arm has some redness; roughness  under skin; This is a spontaneous report from a contactable consumer, the patient. A 66-years- old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EN6200) via an unspecified route of administration in right arm on 12Mar2021at 11:15 (at the age of 66-years-old), as a single dose for COVID-19 immunisation. Medical history included some eczema or psoriasis on lower legs and interstitual cystitus. Patient was allergic to augmentin, macrobid and lemon pepper seasoning. The patient did not receive any other medication within 2 weeks of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. The patient had not tested for COVID-19 since the vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17Mar2021 at 10:00 after the fifth day of the shot, the patient experienced red rash on waistline on the patient right side about the size of the palm of the hand, a little itchy but under skin (not raised) and the patient right lower arm has some redness and roughness but still under the skin. The events result in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events, included treatment with Benadryl. The clinical outcome of red rash on waistline, a little itchy but under skin, redness of right lower arm and roughness under skin were recovering at the time of report.   No follow-up attempts are needed. No further information is expected.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dry skin, Erythema, Pruritus, Rash erythematous
Clinical narrative: red rash on  waistline; little itchy  under skin; right lower arm has some redness; roughness  under skin; This is a spontaneous report from a contactable consumer, the patient. A 66-years- old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EN6200) via an unspecified route of administration in right arm on 12Mar2021at 11:15 (at the age of 66-years-old), as a single dose for COVID-19 immunisation. Medical history included some eczema or psoriasis on lower legs and interstitual cystitus. Patient was allergic to augmentin, macrobid and lemon pepper seasoning. The patient did not receive any other medication within 2 weeks of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. The patient had not tested for COVID-19 since the vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17Mar2021 at 10:00 after the fifth day of the shot, the patient experienced red rash on waistline on the patient right side about the size of the palm of the hand, a little itchy but under skin (not raised) and the patient right lower arm has some redness and roughness but still under the skin. The events result in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events, included treatment with Benadryl. The clinical outcome of red rash on waistline, a little itchy but under skin, redness of right lower arm and roughness under skin were recovering at the time of report.   No follow-up attempts are needed. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain, Arthralgia, Dizziness, Dyspnoea, Feeling abnormal
Clinical narrative: nausea; Around 2pm started havingcramps as id period was on but its notdue for a week, severe abdominal cramps; shortness of breath; Itching; Arm pain; Shoulder pain; Neck pain; Dizziness; Just felt weird.; This is a spontaneous report from a contactable consumer, the patient. A 38-years-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Er8727) in the arm left on 23Mar2021 at 08:00 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. Medical history included allergies not otherwise specified, asthma, obesity. The patient is allergic to mango, nuts, shellfish, soy, wheat, corn, coconut, milk. Prior to vaccination the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications included cetirizine hydrochloride (ZYRTEC), lansoprazole (PREVACID), diphenhydramine (BENADRYL), Sertraline (ZOLOFT), Ibuprofen (ADVIL), albuterol (MANUFACTURER UNKNOWN) all for an unknown indication since an unknown date. On 23Mar2021, the patient experienced itching a few minutes after receiving the shot. Felt slight shortness of breath but wasn't sure if it was having panic attack or reaction. The patient took BENADRYL and used inhaler that helped around. Around 14:00, the patient had cramps as period was on but its not due for a week. Took ADVIL, it helped. Around 17:30, the patient experienced severe abdominal cramps, nausea, went to bathroom several times. The patient experienced arm, neck and shoulder pain. Dizziness and just feel weird. The patient reported that if condition gets worse tonight will go to ER, if same or better she will call doctor in the morning. The patient had received treatment for shortness of breath and abdominal cramps while that of the other events were unknown. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures and treatments included inhaler, ADVIL and BENADRYL for the events shortness of breath, itching and abdominal cramps and it was unknown that patient received treatment for the other events. The outcome of the events shortness of breath, itching and period cramps was resolving while that of the events nausea, arm, neck and shoulder pain, dizziness and weird feeling was unknown at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Menstruation irregular, Muscle spasms, Nausea, Neck pain, Pain in extremity
Clinical narrative: nausea; Around 2pm started havingcramps as id period was on but its notdue for a week, severe abdominal cramps; shortness of breath; Itching; Arm pain; Shoulder pain; Neck pain; Dizziness; Just felt weird.; This is a spontaneous report from a contactable consumer, the patient. A 38-years-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Er8727) in the arm left on 23Mar2021 at 08:00 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. Medical history included allergies not otherwise specified, asthma, obesity. The patient is allergic to mango, nuts, shellfish, soy, wheat, corn, coconut, milk. Prior to vaccination the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications included cetirizine hydrochloride (ZYRTEC), lansoprazole (PREVACID), diphenhydramine (BENADRYL), Sertraline (ZOLOFT), Ibuprofen (ADVIL), albuterol (MANUFACTURER UNKNOWN) all for an unknown indication since an unknown date. On 23Mar2021, the patient experienced itching a few minutes after receiving the shot. Felt slight shortness of breath but wasn't sure if it was having panic attack or reaction. The patient took BENADRYL and used inhaler that helped around. Around 14:00, the patient had cramps as period was on but its not due for a week. Took ADVIL, it helped. Around 17:30, the patient experienced severe abdominal cramps, nausea, went to bathroom several times. The patient experienced arm, neck and shoulder pain. Dizziness and just feel weird. The patient reported that if condition gets worse tonight will go to ER, if same or better she will call doctor in the morning. The patient had received treatment for shortness of breath and abdominal cramps while that of the other events were unknown. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures and treatments included inhaler, ADVIL and BENADRYL for the events shortness of breath, itching and abdominal cramps and it was unknown that patient received treatment for the other events. The outcome of the events shortness of breath, itching and period cramps was resolving while that of the events nausea, arm, neck and shoulder pain, dizziness and weird feeling was unknown at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pruritus
Clinical narrative: nausea; Around 2pm started havingcramps as id period was on but its notdue for a week, severe abdominal cramps; shortness of breath; Itching; Arm pain; Shoulder pain; Neck pain; Dizziness; Just felt weird.; This is a spontaneous report from a contactable consumer, the patient. A 38-years-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Er8727) in the arm left on 23Mar2021 at 08:00 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. Medical history included allergies not otherwise specified, asthma, obesity. The patient is allergic to mango, nuts, shellfish, soy, wheat, corn, coconut, milk. Prior to vaccination the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications included cetirizine hydrochloride (ZYRTEC), lansoprazole (PREVACID), diphenhydramine (BENADRYL), Sertraline (ZOLOFT), Ibuprofen (ADVIL), albuterol (MANUFACTURER UNKNOWN) all for an unknown indication since an unknown date. On 23Mar2021, the patient experienced itching a few minutes after receiving the shot. Felt slight shortness of breath but wasn't sure if it was having panic attack or reaction. The patient took BENADRYL and used inhaler that helped around. Around 14:00, the patient had cramps as period was on but its not due for a week. Took ADVIL, it helped. Around 17:30, the patient experienced severe abdominal cramps, nausea, went to bathroom several times. The patient experienced arm, neck and shoulder pain. Dizziness and just feel weird. The patient reported that if condition gets worse tonight will go to ER, if same or better she will call doctor in the morning. The patient had received treatment for shortness of breath and abdominal cramps while that of the other events were unknown. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures and treatments included inhaler, ADVIL and BENADRYL for the events shortness of breath, itching and abdominal cramps and it was unknown that patient received treatment for the other events. The outcome of the events shortness of breath, itching and period cramps was resolving while that of the events nausea, arm, neck and shoulder pain, dizziness and weird feeling was unknown at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nausea, Neck pain, Pain in extremity, Pruritus
Clinical narrative: nausea; Around 2pm started havingcramps as id period was on but its notdue for a week, severe abdominal cramps; shortness of breath; Itching; Arm pain; Shoulder pain; Neck pain; Dizziness; Just felt weird.; This is a spontaneous report from a contactable consumer, the patient. A 38-years-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Er8727) in the arm left on 23Mar2021 at 08:00 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. Medical history included allergies not otherwise specified, asthma, obesity. The patient is allergic to mango, nuts, shellfish, soy, wheat, corn, coconut, milk. Prior to vaccination the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications included cetirizine hydrochloride (ZYRTEC), lansoprazole (PREVACID), diphenhydramine (BENADRYL), Sertraline (ZOLOFT), Ibuprofen (ADVIL), albuterol (MANUFACTURER UNKNOWN) all for an unknown indication since an unknown date. On 23Mar2021, the patient experienced itching a few minutes after receiving the shot. Felt slight shortness of breath but wasn't sure if it was having panic attack or reaction. The patient took BENADRYL and used inhaler that helped around. Around 14:00, the patient had cramps as period was on but its not due for a week. Took ADVIL, it helped. Around 17:30, the patient experienced severe abdominal cramps, nausea, went to bathroom several times. The patient experienced arm, neck and shoulder pain. Dizziness and just feel weird. The patient reported that if condition gets worse tonight will go to ER, if same or better she will call doctor in the morning. The patient had received treatment for shortness of breath and abdominal cramps while that of the other events were unknown. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures and treatments included inhaler, ADVIL and BENADRYL for the events shortness of breath, itching and abdominal cramps and it was unknown that patient received treatment for the other events. The outcome of the events shortness of breath, itching and period cramps was resolving while that of the events nausea, arm, neck and shoulder pain, dizziness and weird feeling was unknown at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Feeling abnormal, Headache, Injection site rash, Injection site warmth
Clinical narrative: hot to the touch; General mental fogginess; rash on right elbow; Sore joints in right arm; skin red; Headache; This is a spontaneous report from a contactable consumer, the patient. A 31-years-old non-pregnant female patient received first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, lot number: ER8727) via an unspecified route of administration in left arm on 21Mar2021 at 12:00, (age at vaccination 31 years) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included mili birth control and loratadine (CLARITIN) for an unknown indication. The patient had no known allergies. Prior to vaccination, the patient did not diagnose with COVID-19. Since the vaccination, the patient did not test for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 22Mar2021 08:00, the patient experienced skin red, skin warm, rash, joint pain, headache and general mental fogginess. No therapeutic measures were taken for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events skin red, skin warm, rash, joint pain, headache and general mental fogginess was recovering at the time of this report.    No follow-up attempts are needed. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash erythematous
Clinical narrative: hot to the touch; General mental fogginess; rash on right elbow; Sore joints in right arm; skin red; Headache; This is a spontaneous report from a contactable consumer, the patient. A 31-years-old non-pregnant female patient received first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, lot number: ER8727) via an unspecified route of administration in left arm on 21Mar2021 at 12:00, (age at vaccination 31 years) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included mili birth control and loratadine (CLARITIN) for an unknown indication. The patient had no known allergies. Prior to vaccination, the patient did not diagnose with COVID-19. Since the vaccination, the patient did not test for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 22Mar2021 08:00, the patient experienced skin red, skin warm, rash, joint pain, headache and general mental fogginess. No therapeutic measures were taken for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events skin red, skin warm, rash, joint pain, headache and general mental fogginess was recovering at the time of this report.    No follow-up attempts are needed. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Erythema, Feeling abnormal, Headache, Rash
Clinical narrative: hot to the touch; General mental fogginess; rash on right elbow; Sore joints in right arm; skin red; Headache; This is a spontaneous report from a contactable consumer, the patient. A 31-years-old non-pregnant female patient received first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, lot number: ER8727) via an unspecified route of administration in left arm on 21Mar2021 at 12:00, (age at vaccination 31 years) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included mili birth control and loratadine (CLARITIN) for an unknown indication. The patient had no known allergies. Prior to vaccination, the patient did not diagnose with COVID-19. Since the vaccination, the patient did not test for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 22Mar2021 08:00, the patient experienced skin red, skin warm, rash, joint pain, headache and general mental fogginess. No therapeutic measures were taken for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events skin red, skin warm, rash, joint pain, headache and general mental fogginess was recovering at the time of this report.    No follow-up attempts are needed. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Skin warm
Clinical narrative: hot to the touch; General mental fogginess; rash on right elbow; Sore joints in right arm; skin red; Headache; This is a spontaneous report from a contactable consumer, the patient. A 31-years-old non-pregnant female patient received first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, lot number: ER8727) via an unspecified route of administration in left arm on 21Mar2021 at 12:00, (age at vaccination 31 years) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included mili birth control and loratadine (CLARITIN) for an unknown indication. The patient had no known allergies. Prior to vaccination, the patient did not diagnose with COVID-19. Since the vaccination, the patient did not test for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 22Mar2021 08:00, the patient experienced skin red, skin warm, rash, joint pain, headache and general mental fogginess. No therapeutic measures were taken for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events skin red, skin warm, rash, joint pain, headache and general mental fogginess was recovering at the time of this report.    No follow-up attempts are needed. No further information is expected.
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Urticaria
Clinical narrative: Hives beginning small on my legs and gradually increasing in size and areas of my body. Primarily on my thighs.; This is a spontaneous report from a contactable consumer, the patient. A 72-years-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: WN6207) via unspecified route of administration on 12Mar2021 at 10:30 as a single dose for COVID-19 immunisation. The medical history was reported as high blood pressure and high cholesterol. Prior to vaccination, the patient was not diagnosed with COVID-19. The concomitant medications were not reported. The patient had received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: UNKNOWN) via unspecified route of administration on an unspecified date as a single dose for COVID-19 immunisation. The patient had not received any other vaccines within 4 weeks prior to the vaccine. Since the vaccination, the patient had not been tested for COVID-19. On 14Mar2021, two days after receiving the dose the patient experienced hives which began small on her legs and gradually increased in size and areas of her body. Primarily on her thighs (hives). No therapeutic measures were taken for the event. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event hives was not recovered at the time of this report.   No follow-up attempts needed. No further information expected.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Immune thrombocytopenia
Clinical narrative: Platelets of 19, Idiopathic thrombocytopenic purpura
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Full blood count, Immune thrombocytopenia, Platelet count decreased
Clinical narrative: Platelets of 19, Idiopathic thrombocytopenic purpura
Age: 26.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Contusion
Clinical narrative: Dark yellow bruises on right side; This is a spontaneous report received from a contactable consumer, the patient. A 26-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955), via unspecified route of administration in the right arm on 22Mar2021 (Monday) at 13:30 (at the age of 26 year-old) as single dose for COVID-19 immunisation. Medical history included cochlear implant in left ear and COVID-19. Concomitant medications included ethinylestradiol, norgestimate (TRI-LO-MARZIA) taken for an unspecified indication from an unknown date. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was diagnosed with COVID-19. The patient had not tested for COVID-19, since the vaccination. On 23Mar2021 (Tuesday), the patient experienced dark yellow bruises on right side, one on arm, four on thigh. All ranging in sizes from dime sized to quarter size. The patient did not receive any treatment for the adverse event. The adverse event did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome for the event bruises was unknown.   No follow-up attempts are needed. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pruritus, Urticaria
Clinical narrative: This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8732) via an unspecified route of administration in left arm on 23Mar2021 at 16:45 (at the age of 36-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. The patient was allergic to eggs it upset her stomach. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included fluticasone propionate (FLONASE) for unknown indication. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Since the vaccination, the patient was not tested for COVID-19. On 23Mar2021 at 17:15, the patient experienced about 30 min after getting the vaccine started to get itchy arms. About an hour after she realized she had hives all on her legs and arm with extreme itching. The patient did not received treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of itchy arm and hives all on legs and arms were resolved on 23Mar2021.  No follow-up attempts are possible. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Joint swelling, Peripheral swelling
Clinical narrative: Severe Swollen lower extremities lower legs and ankles ongoing for 4 days. Still swollen, swelling has not subsided; Severe Swollen lower extremities lower legs and ankles ongoing for 4 days. Still swollen, swelling has not subsided; Bilateral pitting edema ongoing; This is a spontaneous report from a contactable consumer or other non-healthcare professional (patient herself).   A 31-years-old non-pregnant female patient (not pregnant at the time of vaccination) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: ER8732), dose 1 via an unspecified route of administration, administered in Arm Left on 31Mar2021 12:00 PM (at the age of 31-years-old) as dose 1, single for covid-19 immunisation at Pharmacy or Drug Store. The patient's medical history was not reported. The patient's concomitant medications included buprenorphine HCL (BUPRENORPHINE HCL) 8 mg taken for an unspecified indication and phenylephrine hydrochloride (SINEX [PHENYLEPHRINE HYDROCHLORIDE]) nose spray taken for an unspecified indication. The patient previously took Cephalosporin medications and experienced allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient not tested for COVID-19. On 06Apr2021, Bilateral pitting edema ongoing since, She had seen primary care, vascular specialists, and a cardiologist and incurred over a thousand dollars in medical bills due to this event. No hospitalization required for the event. On 07Apr2021, the patient experienced severe Swollen lower extremities lower legs and ankles ongoing for 4 days. Still swollen, swelling has not subsided. The patient did not receive treatment for event severe Swollen lower extremities lower legs and ankles. For bilateral pitting edema ongoing she has been prescribed Lasix which causes a severe disruption to her everyday life due to urination frequency while taking the medication. The patient also had radiology testing, lab work and results were not reported. The adverse event result in doctor or other healthcare professional office/clinic visit. The outcome of the events were not resolved.